Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Concern Explaining Nonresponsive Feeding: A Study of Mothers' and Fathers' Response to Their Child's Fussy Eating.

Harris HA, Jansen E, Mallan KM, Daniels L, Thorpe K.

J Nutr Educ Behav. 2018 Sep;50(8):757-764. doi: 10.1016/j.jneb.2018.05.021.

PMID:
30196882
2.

Do Dads Make a Difference? Family Feeding Dynamics and Child Fussy Eating.

Harris HA, Jansen E, Mallan KM, Daniels L, Thorpe K.

J Dev Behav Pediatr. 2018 Jun;39(5):415-423. doi: 10.1097/DBP.0000000000000566.

PMID:
29608454
3.

What's the fuss about? Parent presentations of fussy eating to a parenting support helpline.

Harris HA, Ria-Searle B, Jansen E, Thorpe K.

Public Health Nutr. 2018 Jun;21(8):1520-1528. doi: 10.1017/S1368980017004049. Epub 2018 Feb 1.

PMID:
29386082
4.

Measurement invariance of the Feeding Practices and Structure Questionnaire-28 among a community of socioeconomically disadvantaged mothers and fathers.

Jansen E, Harris HA, Mallan KM, Daniels L, Thorpe K.

Appetite. 2018 Jan 1;120:115-122. doi: 10.1016/j.appet.2017.08.030. Epub 2017 Aug 31.

PMID:
28864257
5.

Maternal feeding practices and fussy eating in toddlerhood: a discordant twin analysis.

Harris HA, Fildes A, Mallan KM, Llewellyn CH.

Int J Behav Nutr Phys Act. 2016 Jul 13;13:81. doi: 10.1186/s12966-016-0408-4.

6.

Emergency Physicians' Experience with Advance Care Planning Documentation in the Electronic Medical Record: Useful, Needed, and Elusive.

Lakin JR, Isaacs E, Sullivan E, Harris HA, McMahan RD, Sudore RL.

J Palliat Med. 2016 Jun;19(6):632-8. doi: 10.1089/jpm.2015.0486. Epub 2016 May 20.

7.

Starting and Sustaining Palliative Care in Public Hospitals: Lessons Learned from a Statewide Initiative.

Kinderman AL, Harris HA, Brousseau RT, Close P, Pantilat SZ.

J Palliat Med. 2016 Sep;19(9):908-16. doi: 10.1089/jpm.2015.0534. Epub 2016 May 11.

PMID:
27167527
8.

Progress and prospects in treating postmenopausal vaginal atrophy.

Winneker RC, Harris HA.

Clin Pharmacol Ther. 2011 Jan;89(1):129-32. doi: 10.1038/clpt.2010.161. Epub 2010 Oct 13.

PMID:
20944561
9.

Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.

Zhang L, Blackman BE, Schonemann MD, Zogovic-Kapsalis T, Pan X, Tagliaferri M, Harris HA, Cohen I, Pera RA, Mellon SH, Weiner RI, Leitman DC.

PLoS One. 2010 Jul 27;5(7):e11791. doi: 10.1371/journal.pone.0011791.

10.

Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists.

Serova LI, Harris HA, Maharjan S, Sabban EL.

J Endocrinol. 2010 Jun;205(3):253-62. doi: 10.1677/JOE-10-0029. Epub 2010 Mar 26.

11.

A mouse model of androgenetic alopecia.

Crabtree JS, Kilbourne EJ, Peano BJ, Chippari S, Kenney T, McNally C, Wang W, Harris HA, Winneker RC, Nagpal S, Thompson CC.

Endocrinology. 2010 May;151(5):2373-80. doi: 10.1210/en.2009-1474. Epub 2010 Mar 16.

PMID:
20233794
12.

Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study.

Christaki E, Opal SM, Keith JC Jr, Kessinian N, Palardy JE, Parejo NA, Lavallie E, Racie L, Mounts W, Malamas MS, Mewshaw RE, Harris HA, Vlasuk GP.

J Infect Dis. 2010 Apr 15;201(8):1250-7. doi: 10.1086/651276.

PMID:
20205571
13.

Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

McCampbell AS, Harris HA, Crabtree JS, Winneker RC, Walker CL, Broaddus RR.

Cancer Prev Res (Phila). 2010 Mar;3(3):290-300. doi: 10.1158/1940-6207.CAPR-09-0199. Epub 2010 Feb 23.

14.

Trace LC/MS/MS quantitation of 17beta-estradiol as a biomarker for selective estrogen receptor modulator activity in the rat brain.

Petucci C, Lloyd T, Harris HA, Zhang X, Chennathukuzhi VM, Mekonnen B, Cai Y.

J Mass Spectrom. 2010 Jan;45(1):65-71. doi: 10.1002/jms.1689.

PMID:
19882750
15.

Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.

Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, Wilson E, Saraf KA, Liu W, McCampbell AS, Dave B, Broaddus RR, Brown EL, Kao W, Skotnicki JS, Abou-Gharbia M, Winneker RC, Walker CL.

Cancer Res. 2009 Aug 1;69(15):6171-8. doi: 10.1158/0008-5472.CAN-08-4471. Epub 2009 Jul 21.

16.

Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.

Paruthiyil S, Cvoro A, Zhao X, Wu Z, Sui Y, Staub RE, Baggett S, Herber CB, Griffin C, Tagliaferri M, Harris HA, Cohen I, Bjeldanes LF, Speed TP, Schaufele F, Leitman DC.

PLoS One. 2009 Jul 17;4(7):e6271. doi: 10.1371/journal.pone.0006271.

17.

Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.

Peano BJ, Crabtree JS, Komm BS, Winneker RC, Harris HA.

Endocrinology. 2009 Apr;150(4):1897-903. doi: 10.1210/en.2008-1210. Epub 2008 Nov 20.

PMID:
19022889
18.

Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats.

Harris HA, Chennathukuzhi VM, Zhang X, Mekonnen B, Jelinsky SA, Schelling SH, Patel VS, Huselton C, Negahban A, Azam F, Winneker RC.

J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):40-6. doi: 10.1016/j.jsbmb.2008.08.008. Epub 2008 Sep 4.

PMID:
18824103
19.

Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.

Jelinsky SA, Choe SE, Crabtree JS, Cotreau MM, Wilson E, Saraf K, Dorner AJ, Brown EL, Peano BJ, Zhang X, Winneker RC, Harris HA.

BMC Med Genomics. 2008 Jun 25;1:27. doi: 10.1186/1755-8794-1-27.

20.

Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.

Crabtree JS, Peano BJ, Zhang X, Komm BS, Winneker RC, Harris HA.

Mol Cell Endocrinol. 2008 Jun 11;287(1-2):40-6. doi: 10.1016/j.mce.2008.01.027. Epub 2008 Feb 12.

PMID:
18367319
21.

Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.

Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC.

J Immunol. 2008 Jan 1;180(1):630-6.

22.

A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.

Cotreau MM, Chennathukuzhi VM, Harris HA, Han L, Dorner AJ, Apseloff G, Varadarajan U, Hatstat E, Zakaria M, Strahs AL, Crabtree JS, Winneker RC, Jelinsky SA.

Maturitas. 2007 Dec 20;58(4):366-76. Epub 2007 Nov 9.

PMID:
17997058
23.
24.

ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands.

Vu AT, Campbell AN, Harris HA, Unwalla RJ, Manas ES, Mewshaw RE.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):4053-6. Epub 2007 May 4.

PMID:
17482813
25.

ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.

Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.

Bioorg Med Chem Lett. 2007 Feb 15;17(4):902-6. Epub 2006 Dec 1.

PMID:
17188490
26.

An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.

Leventhal L, Brandt MR, Cummons TA, Piesla MJ, Rogers KE, Harris HA.

Eur J Pharmacol. 2006 Dec 28;553(1-3):146-8. Epub 2006 Sep 26.

PMID:
17056036
27.

Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones.

Ullrich JW, Unwalla RJ, Singhaus RR Jr, Harris HA, Mewshaw RE.

Bioorg Med Chem Lett. 2007 Jan 1;17(1):118-22. Epub 2006 Oct 1.

PMID:
17049855
28.

Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.

Crabtree JS, Zhang X, Peano BJ, Zhang Z, Winneker RC, Harris HA.

J Steroid Biochem Mol Biol. 2006 Sep;101(1):11-21. Epub 2006 Aug 22.

PMID:
16920353
29.
30.

WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock.

Cristofaro PA, Opal SM, Palardy JE, Parejo NA, Jhung J, Keith JC Jr, Harris HA.

Crit Care Med. 2006 Aug;34(8):2188-93.

PMID:
16755255
31.

Estrogen receptor-beta: recent lessons from in vivo studies.

Harris HA.

Mol Endocrinol. 2007 Jan;21(1):1-13. Epub 2006 Mar 23. Review.

PMID:
16556737
32.

Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041.

Follettie MT, Pinard M, Keith JC Jr, Wang L, Chelsky D, Hayward C, Kearney P, Thibault P, Paramithiotis E, Dorner AJ, Harris HA.

Endocrinology. 2006 Feb;147(2):714-23. Epub 2005 Nov 3.

PMID:
16269464
33.

ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives.

Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4520-5.

PMID:
16098741
34.

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity.

Komm BS, Kharode YP, Bodine PV, Harris HA, Miller CP, Lyttle CR.

Endocrinology. 2005 Sep;146(9):3999-4008. Epub 2005 Jun 16.

PMID:
15961563
35.

ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.

Mewshaw RE, Edsall RJ Jr, Yang C, Manas ES, Xu ZB, Henderson RA, Keith JC Jr, Harris HA.

J Med Chem. 2005 Jun 16;48(12):3953-79.

PMID:
15943471
36.

Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.

McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.

Bioorg Med Chem Lett. 2005 Jun 15;15(12):3137-42.

PMID:
15876535
37.

Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.

Elloso MM, Phiel K, Henderson RA, Harris HA, Adelman SJ.

J Endocrinol. 2005 May;185(2):243-52.

PMID:
15845917
38.

Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.

Chadwick CC, Chippari S, Matelan E, Borges-Marcucci L, Eckert AM, Keith JC Jr, Albert LM, Leathurby Y, Harris HA, Bhat RA, Ashwell M, Trybulski E, Winneker RC, Adelman SJ, Steffan RJ, Harnish DC.

Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2543-8. Epub 2005 Feb 7.

39.

A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.

Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, Lyttle CR.

Hum Reprod. 2005 Apr;20(4):936-41. Epub 2004 Dec 23.

PMID:
15618247
40.

Structure-based design of estrogen receptor-beta selective ligands.

Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC.

J Am Chem Soc. 2004 Nov 24;126(46):15106-19.

PMID:
15548008
41.

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.

J Med Chem. 2004 Oct 7;47(21):5021-40.

PMID:
15456246
42.

7-Substituted 2-phenyl-benzofurans as ER beta selective ligands.

Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.

Bioorg Med Chem Lett. 2004 Oct 4;14(19):4925-9.

PMID:
15341953
43.

ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.

Yang C, Edsall R Jr, Harris HA, Zhang X, Manas ES, Mewshaw RE.

Bioorg Med Chem. 2004 May 15;12(10):2553-70.

PMID:
15110838
44.

Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.

Bhat RA, Stauffer B, Unwalla RJ, Xu Z, Harris HA, Komm BS.

J Steroid Biochem Mol Biol. 2004 Jan;88(1):17-26.

PMID:
15026080
45.

Using hydrophilic adhesive tape for collection of evidence for forensic DNA analysis.

Li RC, Harris HA.

J Forensic Sci. 2003 Nov;48(6):1318-21.

PMID:
14640278
46.

Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry.

Mallis LM, Sarkahian AB, Harris HA, Zhang MY, McConnell OJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 25;796(1):71-86.

PMID:
14552818
47.

Evaluation of an estrogen receptor-beta agonist in animal models of human disease.

Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC Jr.

Endocrinology. 2003 Oct;144(10):4241-9. Erratum in: Endocrinology. 2006 May;147(5):2085.

PMID:
14500559
48.

ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template.

Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE.

Bioorg Med Chem. 2003 Aug 5;11(16):3457-74.

PMID:
12878140
49.

Constrained phytoestrogens and analogues as ERbeta selective ligands.

Miller CP, Collini MD, Harris HA.

Bioorg Med Chem Lett. 2003 Jul 21;13(14):2399-403.

PMID:
12824043
50.

Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.

Labaree DC, Zhang JX, Harris HA, O'Connor C, Reynolds TY, Hochberg RB.

J Med Chem. 2003 May 8;46(10):1886-904.

PMID:
12723952

Supplemental Content

Loading ...
Support Center